Iradimed annual operating margin
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Iradimed's operating margin was 31.20% for fiscal 2025.
View full Iradimed company overview| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | 31.20% | +1.21 pp |
| 2024 | 2024-12-31 | 29.99% | −0.57 pp |
| 2023 | 2023-12-31 | 30.56% | +1.24 pp |
| 2022 | 2022-12-31 | 29.32% | +5.84 pp |
| 2021 | 2021-12-31 | 23.48% | +25.86 pp |
| 2020 | 2020-12-31 | −2.38% | −24.83 pp |
| 2019 | 2019-12-31 | 22.45% | +2.73 pp |
| 2018 | 2018-12-31 | 19.72% | +14.16 pp |
| 2017 | 2017-12-31 | 5.57% | −28.04 pp |
| 2016 | 2016-12-31 | 33.60% | −2.84 pp |
| 2015 | 2015-12-31 | 36.44% | +16.85 pp |
| 2014 | 2014-12-31 | 19.59% | −4.99 pp |
| 2013 | 2013-12-31 | 24.58% | — |
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | 31.23% | −2.03 pp |
| Q1 2026 | 2026-03-31 | 32.93% | +5.09 pp |
| Q4 2025 | 2025-12-31 | 31.26% | +1.34 pp |
| Q3 2025 | 2025-09-30 | 32.23% | +0.64 pp |
| Q2 2025 | 2025-06-30 | 33.26% | +1.87 pp |
| Q1 2025 | 2025-03-31 | 27.84% | +0.86 pp |
| Q4 2024 | 2024-12-31 | 29.92% | +0.35 pp |
| Q3 2024 | 2024-09-30 | 31.59% | −4.19 pp |
| Q2 2024 | 2024-06-30 | 31.39% | +0.62 pp |
| Q1 2024 | 2024-03-31 | 26.98% | +1.09 pp |
| Q4 2023 | 2023-12-31 | 29.57% | +0.95 pp |
| Q3 2023 | 2023-09-30 | 35.78% | +4.96 pp |
| Q2 2023 | 2023-06-30 | 30.77% | −1.98 pp |
| Q1 2023 | 2023-03-31 | 25.89% | +0.92 pp |
| Q4 2022 | 2022-12-31 | 28.62% | +2.43 pp |
| Q3 2022 | 2022-09-30 | 30.82% | +2.52 pp |
| Q2 2022 | 2022-06-30 | 32.75% | +13.95 pp |
| Q1 2022 | 2022-03-31 | 24.98% | +5.71 pp |
| Q4 2021 | 2021-12-31 | 26.19% | +18.57 pp |
| Q3 2021 | 2021-09-30 | 28.30% | +18.11 pp |
| Q2 2021 | 2021-06-30 | 18.80% | +61.91 pp |
| Q1 2021 | 2021-03-31 | 19.27% | +10.77 pp |
| Q4 2020 | 2020-12-31 | 7.62% | −12.94 pp |
| Q3 2020 | 2020-09-30 | 10.19% | −15.09 pp |
| Q2 2020 | 2020-06-30 | −43.11% | −68.86 pp |
| Q1 2020 | 2020-03-31 | 8.50% | −9.45 pp |
| Q4 2019 | 2019-12-31 | 20.56% | −0.94 pp |
| Q3 2019 | 2019-09-30 | 25.28% | +6.26 pp |
| Q2 2019 | 2019-06-30 | 25.75% | +3.04 pp |
| Q1 2019 | 2019-03-31 | 17.94% | +2.64 pp |
| Q4 2018 | 2018-12-31 | 21.50% | +6.59 pp |
| Q3 2018 | 2018-09-30 | 19.02% | +15.57 pp |
| Q2 2018 | 2018-06-30 | 22.71% | +16.78 pp |
| Q1 2018 | 2018-03-31 | 15.30% | +19.91 pp |
| Q4 2017 | 2017-12-31 | 14.91% | −10.22 pp |
| Q3 2017 | 2017-09-30 | 3.45% | −30.35 pp |
| Q2 2017 | 2017-06-30 | 5.93% | −27.91 pp |
| Q1 2017 | 2017-03-31 | −4.62% | −43.45 pp |
| Q4 2016 | 2016-12-31 | 25.13% | −12.97 pp |
| Q3 2016 | 2016-09-30 | 33.80% | −5.29 pp |
| Q2 2016 | 2016-06-30 | 33.84% | −1.56 pp |
| Q1 2016 | 2016-03-31 | 38.84% | +6.45 pp |
| Q4 2015 | 2015-12-31 | 38.09% | +31.81 pp |
| Q3 2015 | 2015-09-30 | 39.09% | +28.43 pp |
| Q2 2015 | 2015-06-30 | 35.40% | +1.15 pp |
| Q1 2015 | 2015-03-31 | 32.39% | +9.22 pp |
| Q4 2014 | 2014-12-31 | 6.29% | −8.06 pp |
| Q3 2014 | 2014-09-30 | 10.66% | −17.44 pp |
| Q2 2014 | 2014-06-30 | 34.26% | — |
| Q1 2014 | 2014-03-31 | 23.17% | — |
| Q3 2013 | 2013-09-30 | 14.35% | — |
| Q2 2013 | 2013-06-30 | 28.10% | — |
Over the last five reported fiscal years, Iradimed's operating margin increased from −2.38% to 31.20%, a change of +33.58 percentage points. The latest reported quarter, Q2 2026, shows 31.23%.
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Iradimed filings at SEC.gov ↗